CoChat

Safe, Effective, and Inexpensive Clearance of Mycoplasma Contamination from Cultures of Apicomplexan Parasites with Sparfloxacin

Open access

Published version of a preprint

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Abstract

These findings will be useful to laboratories maintaining apicomplexan parasites in vitro , especially in low-resource environments, where the high cost of commercial products creates an economic barrier for detecting and eliminating mycoplasma from culture.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/spectrum.03497-22

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Dose-response curves of apicomplexan parasites to sparfloxacin. (a) Sparfloxacin dose-response curve of Plasmodium falciparum isolates of African (NF54; green), Southeast Asian (Dd2; orange), and South American (HB3; purple) origin based on 72-h SYBR green growth assays. The estimated 50% effective concentrations (EC50) with 95% confidence intervals are indicated based on n = 2 to 3. (b) Sparfloxacin dose-response curves of B. divergens isolate Rouen 1987 and T. gondii were measured using 72-h SYBR green and 96-h luciferase growth assays, respectively. The estimated EC50 values with 95% confidence intervals are indicated based on n = 2 to 3. (c) Representative growth curves of P. falciparum NF54 maintained at 1, 2, or 4 μg/mL sparfloxacin, MRA (0.5 μg/mL), or no drug. Growth rates with 95% confidence intervals are shown in day-1 based on n = 2.
FIG 1 Dose-response curves of apicomplexan parasites to sparfloxacin. (a) Sparfloxacin dose-response curve of Plasmodium falciparum isolates of African (NF54; green), Southeast Asian (Dd2; orange), and South American (HB3; purple) origin based on 72-h SYBR green growth assays. The estimated 50% effective concentrations (EC50) with 95% confidence intervals are indicated based on n = 2 to 3. (b) Sparfloxacin dose-response curves of B. divergens isolate Rouen 1987 and T. gondii were measured using 72-h SYBR green and 96-h luciferase growth assays, respectively. The estimated EC50 values with 95% confidence intervals are indicated based on n = 2 to 3. (c) Representative growth curves of P. falciparum NF54 maintained at 1, 2, or 4 μg/mL sparfloxacin, MRA (0.5 μg/mL), or no drug. Growth rates with 95% confidence intervals are shown in day-1 based on n = 2.CC BY · PubMed Central
FIG 2 Detection of mycoplasma in P. falciparum cultures with commercial or in-house PCR assays. A commercial PCR assay was able to detect mycoplasma in the DNA of mycoplasma-positive (myco+) cultures even at 1:1,000 dilution, while the limit of detection for the in-house assay was between 1:100 and 1:1,000. The results from the undiluted mycoplasma-negative (myco–) and no template (H2O) controls are also shown. Images are representative of n = 2.
FIG 2 Detection of mycoplasma in P. falciparum cultures with commercial or in-house PCR assays. A commercial PCR assay was able to detect mycoplasma in the DNA of mycoplasma-positive (myco+) cultures even at 1:1,000 dilution, while the limit of detection for the in-house assay was between 1:100 and 1:1,000. The results from the undiluted mycoplasma-negative (myco–) and no template (H2O) controls are also shown. Images are representative of n = 2.CC BY · PubMed Central
FIG 3 Effective clearance of mycoplasma with Sparfloxaxin. (a) Sparfloxacin reduced MRA-sensitive mycoplasma contamination in P. falciparum cultures below the level of detection of the in-house PCR assay after 1 week of treatment at all concentrations tested. (b) Sparfloxacin cleared MRA-resistant mycoplasma species from P. falciparum cultures after 1 week of treatment at 4 μg/mL, when MRA at the recommended 0.5 μg/mL failed even after 3 weeks of treatment. Mycoplasma was detected using the in-house PCR assay, and images are representative of n = 2. UT, untreated.
FIG 3 Effective clearance of mycoplasma with Sparfloxaxin. (a) Sparfloxacin reduced MRA-sensitive mycoplasma contamination in P. falciparum cultures below the level of detection of the in-house PCR assay after 1 week of treatment at all concentrations tested. (b) Sparfloxacin cleared MRA-resistant mycoplasma species from P. falciparum cultures after 1 week of treatment at 4 μg/mL, when MRA at the recommended 0.5 μg/mL failed even after 3 weeks of treatment. Mycoplasma was detected using the in-house PCR assay, and images are representative of n = 2. UT, untreated.CC BY · PubMed Central
FIG 4 Mycoplasma detection PCR master mix composition (left) and cycling conditions (right). Indicated volumes are in microliters.
FIG 4 Mycoplasma detection PCR master mix composition (left) and cycling conditions (right). Indicated volumes are in microliters.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. McGarrity GJ, Barile MF. 1983. Methods in mycoplasmology: diagnostic mycoplasmology, vol 2. Academic Press, New York, NY.
  2. Schlichtherle M, Wahlgren M, Perlmann H, Scherf A (ed). 2000. Methods in malaria research, 3rd ed. MR4/American Type Culture Collection, Manassas, VA.

Cited by

See all 6

Metadata

Authors
Malave-Ramos, D. R., Kennedy, K., Key, M. N., Dou, Z., & Kafsack, B. F. C.
Affiliations
  • Cornell University (US)
  • Weill Cornell Medicine (US)
  • Clemson University (US)
Corresponding author
  • Kennedy, Kit
  • Kafsack, Björn F. C.
Venue
Microbiology Spectrum
Published
2022-10-26
Volume
10
Issue
5
Pages
e0349722-e0349722
ISSN
2165-0497 (ISSN-L)
OpenAlex
W4300690496
Cited by
4
References
23
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1
FWCI
0.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbiology Spectrum (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (1R01 AI141965, 1R01 AI138499, 1R21 AI166436, 1R01 AI143707)
  • Frueauff Family Foundation
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Life Sciences › Immunology and Microbiology › Parasitology › Toxoplasma gondii Research Studies
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
mycoplasma contamination, Apicomplexa, sparfloxacin, low-resource laboratories
MeSH terms
Animals, Anti-Bacterial Agents, Mycoplasma, Parasites, Fluoroquinolones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.